Found 6 matching trials
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
PHASE3The purpose of this study is to obtain safety, efficacy, and pharmacodynami...
Status
Enrolling By Invitation
Location
Clinical Trial Site
Evuzamitide in PET/CT to Measure Potential Therapeutic Response in ATTR
PHASE2This was a single center, prospective cohort study that is evaluating the a...
Location
Columbia University Irving Medical Center
HELIOS-B: A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
PHASE3This study will evaluate the efficacy and safety of vutrisiran 25 mg admini...
Status
Active Not Recruiting
Location
Clinical Trial Site
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
PHASE3The purpose of this study is to:
* Determine the efficacy of nucresiran in...
Location
Clinical Trial Site
HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)
PHASE3The purpose of this study is to evaluate the efficacy and safety of vutrisi...
Location
Clinical Trial Site
Myocardial Effects in Patients With ATTRv With Polyneuropathy Treated With Patisiran or Vutrisiran
N/AATTRv amyloidosis is a systemic disease with two clinical forms, neurologic...
Status
Active Not Recruiting
Location
CHU Bordeaux Haut-Levêque